[Hiring] Clinical Safety Coordinator @Sarah Cannon Research Institute

Role Description

The Safety Coordinator acts as the primary drug safety representative and contact for investigational sites, SCRI project teams for Investigator Initiated Trials (IITs) and Research Collaboration Trials. This is a fully remote position in the US; relocation assistance and visa sponsorship are not available.

• Manage the receipt, processing, and electronic filing of IND Safety Reports (INDSRs) in alignment with SCRI policies and Sponsor-designated distribution methods.
• Retrieve safety reports from sponsor/CRO portals or direct email and upload into the electronic repository with required metadata.
• Support distribution of safety report metadata to investigators for review and acknowledgment via internal systems.
• Other duties as assigned.

Qualifications

• Associate's Degree or Bachelor Degree preferred; experience may be substituted for education.
• Work experience with all Microsoft Office products including Excel, and varying software applications or databases.
• 2+ years Data Entry experience in a hospital, medical office, or research environment requiring a high-level of attention to detail preferred.
• Experience and ability to appropriately manage and prioritize assigned tasks and adhere to specific deadlines.

Benefits

• Comprehensive benefits to support physical, mental, and financial well-being.
• Competitive compensation package determined by performance, experience, skills, equity, regular job market evaluations, and geographical markets.
• Other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

Company Description

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.